Star

Star Sports Medicine Co., Ltd. ("Star"), as a leader in domestically produced sports medicine in China, is committed to providing comprehensive clinical solutions for sports medicine. The company is located in Beijing Economic-Technological Development Area, with a registered capital of over 40 million yuan and more than 200 employees. More than 300 product specifications of sports medicine equipment, implants, and surgical instruments used for shoulder, knee, foot/ankle, hip, elbow, and hand/wrist joints have been approved by NMPA, and are clinically applied in thousands of hospitals across 31 provinces, municipalities, and autonomous regions in China. The company has made breakthroughs in several key technologies such as injection molding, weaving, preparation and processing of absorbable materials, and active device development for sports medicine products. It has established a complete quality management system, with 13 product specifications certified by the EU CE, ISO9001, ISO13485, and national GMP standards, making it a domestic enterprise capable of providing comprehensive clinical solutions for sports medicine. Adhering to the philosophy of "regarding products as if they were for personal use," the company benchmarks itself against international advanced standards, introducing world-leading processing centers, precision injection molding machines, weaving machines, and other specialized equipment to achieve GMP-compliant cleanroom production. The company has formed an interdisciplinary team focused on design, R&D, production, medical science, clinical practice, and marketing, collaborating with numerous doctors and experts at home and abroad. It holds over 100 core invention patents and undertakes multiple national major projects and research plans from the Beijing Municipal Science & Technology Commission. More than ten products have received new technology and new product certifications from the Beijing Municipal Science & Technology Commission. Star is recognized as a national-level specialized, refined, distinctive, and innovative "little giant" enterprise, a national high-tech enterprise, a Beijing specialized, refined, distinctive, and innovative enterprise, a Zhongguancun Golden Seed Enterprise, and a Zhongguancun high-tech enterprise. It was ranked among the Top 50 High-tech High-growth Enterprises in China (2020), the Yizhuang Rising Star High-tech High-growth Enterprise List (2020), China's Rising Stars (2020), Beijing Zhongguancun Gazelle Enterprise (2021), Top 10 Frontier Medical Device Enterprises in Zhongguancun (2021), KPMG China Biotech Innovation Top 50 (2022), and Future Healthcare Top 100 (2022).